VEGFR2/CD309 Protéine

N° du produit ABIN2132531

Protéine Recombinant VEGFR2/CD309 exprimée dans Insect cells (Sf9).

Aperçu rapide pour VEGFR2/CD309 Protéine (ABIN2132531)

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Type de proteíne: Recombinant

Origine: Humain

Source: Insect cells (Sf9)

Pureté: > 90 % pure

Détail du produit

Attributs du produit: Purified recombinant Human VEGFR2 protein
Expression System: Sf-9 insect cells

niveau d'endotoxine: < 0.1 ng per μg of sKDR

Information d'application

Indications d'application: Each Investigator should determine their own optimal working dilution for specific applications.

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Reconstitute in PBS or sterile water to a concentration of > 100 ng/mL.

Buffer: Supplied as a lyophilized powder.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: -20 °C

Stockage commentaire: Ships ambient or refrigerated. Upon receipt store at -20 °C.

Détail du antigène

Antigène: VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))

Autre désignation: VEGFR2

Sujet: Human soluble Endothelial Growth Factor Receptor-2 consists of all 7 extracellular domains, which contain all the information necessary for high affinity ligand binding. Endothelial cells express three different vascular endothelial growth factor (VEGF) receptors, belonging to the family of receptor tyrosine kinases (RTKs). They are named VEGFR-1 (Flt-1), VEGFR-2 (kDaR/Flk-1), VEGFR-3 (Flt-4).
Alternative Names: D1-7 protein, VEGF-R2 protein, Vascular Endothelial Growth Factor Receptor 2 protein, KDR protein

Poids moléculaire: 116 kDa

Pathways: Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling